Decision-dodgers enable flawed blockers trial

TL;DR

Puberty Blockers Lobby: Around 200 people lobbied MPs on March 10 to demand analysis of existing data and a permanent ban on puberty blockers for children.
Trial Paused Indefinitely: A proposed trial of blockers on 200 children was approved last year but paused in February after safety and ethics concerns raised by MHRA officer Professor Jacob George.[[1]](https://thecritic.co.uk/the-decision-dodgers/)[[2]](https://thecritic.co.uk/the-decision-dodgers)
Institutional Failure Argued: Author Helen Joyce claims regulators like MHRA and ethics committees outsourced decisions, allowing a flawed trial design that ignores long-term harms like infertility.

The story at a glance

Helen Joyce recounts a March 10 lobby day where groups including Sex Matters urged MPs to oppose a puberty blockers trial for gender-distressed children. The trial, tracking mood in 200 children split between immediate and delayed blockers, was paused in February amid safety concerns from MHRA's Professor Jacob George, who was later recused over past social media posts. This is reported now following the lobby and a March 23 parliamentary debate, amid strong public opposition shown by a petition exceeding 100,000 signatures.

Key points

Public opposes the trial by more than four-to-one; a January petition calling to scrap it hit 100,000 signatures quickly, triggering a debate.
Trial design uses mood questionnaires over two years, with placebo/nocebo effects likely from children's expectations about blockers.
Blockers seen as gateway to cross-sex hormones, which nearly all prior users took; long-term risks like infertility and brittle bones not addressed in short-term study.
UK oversight involves Health Research Authority, MHRA, and 87 ethics committees, yet approved the trial despite flaws.
Professor Jacob George flagged issues but was sidelined after his anti-trans posts in women's sports and praise for J.K. Rowling were publicized.
MPs sympathize with protecting children but defer to experts and institutions.

Details and context

Joyce joined 200 coordinated by Women's Rights Network, LGB Alliance, and Sex Matters in Westminster Hall, using "green card" forms for impromptu MP talks. Many MPs echoed public instincts that children are too young for such decisions but felt unable to override regulators.

The trial's ethical mess stems from diffuse responsibility: multiple bodies mean no one acts, especially with delayed harms and peer criticism risks. Gender-distressed children get passed along a chain from GP to specialists, with no one owning the outcome of chemical castration leading to infertility and likely orgasm incapacity.

Joyce argues medicines regulation should require plain warnings on blockers, akin to finance risks on pensions or mortgages. Politicians, as generalists juggling issues, outsource to rules meant to encode shared values, but these fail here.

Key quotes

"When responsibility is diffuse and the harms are delayed, people are more likely to do nothing." — Helen Joyce.[[1]](https://thecritic.co.uk/the-decision-dodgers/)

Why it matters

Institutions meant to protect children from experimental treatments like puberty blockers are failing due to outsourced decisions and proceduralism. This concretely risks more children facing irreversible harms such as infertility while MPs and regulators dodge moral responsibility. Watch if regulators permanently halt the trial or if Parliament steps in with new rules, though experts' sway may persist.

What changed

Before February, the puberty blockers trial had regulatory approval to proceed after last year. It is now paused indefinitely while MHRA seeks further safety and ethics answers. The pause followed concerns from Professor Jacob George in his new January role.

FAQ

Q: Why was the puberty blockers trial paused?

A: The trial paused in February after MHRA's chief medical officer Professor Jacob George raised safety and ethics issues previously ignored. He was then recused following publicity of his social media posts opposing trans women in sports and praising J.K. Rowling. Regulators are now asking further questions.

Q: What is wrong with the trial's design according to the article?

A: It tracks mood via questionnaires in 200 children, half starting blockers immediately and half waiting a year, risking placebo effects from expectations. It ignores long-term harms like infertility since nearly all blocker users proceed to cross-sex hormones. The short two-year window misses serious delayed risks.

Q: How did a lobby day work on March 10?

A: Around 200 people from Women's Rights Network, LGB Alliance, and Sex Matters visited Parliament, booking meetings or using "green card" forms for impromptu MP talks in Westminster Hall. They sought data analysis on past blocker users, attendance at a March 23 debate, and a permanent ban.

Q: What three requests did lobbyists make to MPs?

A: First, analyse data on children who already took puberty blockers before exposing more. Second, attend the March 23 parliamentary debate. Third, agree blockers harm children and ban them permanently.

[[1]](https://thecritic.co.uk/the-decision-dodgers/)

[[2]](https://thecritic.co.uk/the-decision-dodgers)